PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Fundamental Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA.\', \'Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA.\', \'Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA.\', \'Department of Medicine, University of Washington School of Medicine, Seattle, WA.\', \'Neuroscience Institute, Virginia Mason Medical Center, Seattle, WA.\', \'Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA; and.\', \'Department of Immunology, University of Washington School of Medicine, Seattle, WA.\', \'Center for Fundamental Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA; ebettelli@benaroyaresearch.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.4049/jimmunol.2101142
?:hasPublicationType
?:journal
  • Journal of immunology (Baltimore, Md. : 1950)
is ?:pmid of
?:pmid
?:pmid
  • 35288472
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35288472>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35288472>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all